Wells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $113
Wells Fargo analyst Larry Biegelsen maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $103 to $113.
Share
Why It Matters
A big bank analyst thinks Zimmer Biomet stock could go higher in price. They still say it is fairly priced right now, not a great deal.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.